CANCARINI, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 11.395
EU - Europa 7.089
AS - Asia 5.271
SA - Sud America 1.136
AF - Africa 81
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 14
AN - Antartide 1
Totale 25.003
Nazione #
US - Stati Uniti d'America 11.261
CN - Cina 1.962
SG - Singapore 1.698
IT - Italia 1.688
PL - Polonia 1.548
UA - Ucraina 1.461
BR - Brasile 981
DE - Germania 752
HK - Hong Kong 657
FI - Finlandia 365
GB - Regno Unito 308
VN - Vietnam 307
RU - Federazione Russa 256
FR - Francia 230
IE - Irlanda 215
TR - Turchia 215
IN - India 153
CA - Canada 59
BD - Bangladesh 57
AR - Argentina 54
SE - Svezia 54
BE - Belgio 51
MX - Messico 48
NL - Olanda 48
ID - Indonesia 40
EC - Ecuador 37
IQ - Iraq 30
ZA - Sudafrica 28
CZ - Repubblica Ceca 21
AT - Austria 20
IR - Iran 20
PK - Pakistan 19
ES - Italia 16
VE - Venezuela 16
AU - Australia 15
JP - Giappone 15
PY - Paraguay 15
UZ - Uzbekistan 15
CO - Colombia 14
EG - Egitto 14
EU - Europa 13
SA - Arabia Saudita 13
LT - Lituania 12
MA - Marocco 12
JO - Giordania 10
PE - Perù 9
KZ - Kazakistan 8
RO - Romania 7
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
HN - Honduras 6
CH - Svizzera 5
DZ - Algeria 5
JM - Giamaica 5
KE - Kenya 5
KR - Corea 5
LV - Lettonia 5
OM - Oman 5
TN - Tunisia 5
UY - Uruguay 5
BG - Bulgaria 4
CL - Cile 4
HR - Croazia 4
LB - Libano 4
NP - Nepal 4
PA - Panama 4
BY - Bielorussia 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
KG - Kirghizistan 3
KW - Kuwait 3
PS - Palestinian Territory 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
BB - Barbados 2
BN - Brunei Darussalam 2
CR - Costa Rica 2
GT - Guatemala 2
IL - Israele 2
ML - Mali 2
MU - Mauritius 2
NO - Norvegia 2
PH - Filippine 2
RS - Serbia 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
A1 - Anonimo 1
AL - Albania 1
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BW - Botswana 1
CG - Congo 1
EE - Estonia 1
GE - Georgia 1
GR - Grecia 1
LU - Lussemburgo 1
MD - Moldavia 1
Totale 24.997
Città #
Warsaw 1.546
Fairfield 1.359
Woodbridge 1.152
Jacksonville 1.048
Ashburn 861
Singapore 786
Houston 783
Hong Kong 654
Ann Arbor 618
Chandler 593
Cambridge 591
Seattle 505
Wilmington 463
Princeton 418
Beijing 404
Nanjing 370
New York 243
Dublin 213
Dallas 205
Istanbul 183
Milan 183
Helsinki 163
Los Angeles 143
Nanchang 137
Munich 125
Ho Chi Minh City 119
Dearborn 113
Des Moines 106
The Dalles 103
Buffalo 101
Rome 98
Brescia 97
Hebei 82
Moscow 80
Shenyang 79
São Paulo 77
Jiaxing 76
Changsha 75
San Diego 73
Tianjin 69
Jinan 53
Shanghai 52
Verona 49
Redondo Beach 48
Brussels 47
Hanoi 47
Dong Ket 44
Kunming 40
London 37
Boardman 35
San Francisco 35
Chicago 34
Naples 31
Hangzhou 30
Florence 28
Lanzhou 28
Rio de Janeiro 28
Toronto 28
Belo Horizonte 25
Ningbo 24
Santa Clara 24
Lancaster 23
San Mateo 23
Turku 23
Chennai 22
Turin 22
Atlanta 21
Mexico City 21
Zhengzhou 21
Brno 20
Brooklyn 20
Jakarta 20
Stockholm 20
Augusta 19
Curitiba 19
Falls Church 19
Bologna 18
Monmouth Junction 18
Nuremberg 18
Guangzhou 17
Bari 16
Leawood 16
Taizhou 16
Ardabil 15
Brasília 15
Changchun 15
Genoa 15
Phoenix 15
Bergamo 14
Haikou 14
Norwalk 14
Palermo 14
Quito 14
Montreal 13
Mumbai 13
Poplar 13
Porto Alegre 13
Tashkent 13
Tokyo 13
Catania 12
Totale 16.528
Nome #
Mancata ripopolazione dei B linfociti periferici dopo un singolo ciclo di Rituximab in pazienti con vasculite ANCA associata (AAV) all'esordio mai esposti in precedenza a farmaci immunosoppressivi 1.132
Vasculiti ANCA associate (AAV) con presenza di indicatore sierico di attivazione della via alterna del complemento: valutazione degli outcomes. 431
Incremental peritoneal dialysis: a 10 year single-centre experience 308
PRIMA E DOPO IL TRAPIANTO DI RENE: EMODIALISI VS. DIALISI PERITONEALE. 262
Low-protein diets for chronic kidney disease patients: The Italian experience 258
Recurrent exercise-induced acute renal failure in a young Pakistani man with severe renal hypouricemia and SLC2A9 compound heterozygosity. 244
SOVRAPPESO POST-DIALITICO E INFIAMMAZIONE CRONICA: UNA ASSOCIAZIONE PERICOLOSA. STUDIO PROSPETTICO OSSERVAZIONALE DI 36 MESI. 241
SCLEROSI PERITONEALE INCAPSULANTE IN DIALISI PERITONEALE: UNA “BELVA” IN GABBIA? 228
END-DIALYSIS OVERWEIGHT AND CHRONIC INFLAMMATION. A DANGEROUS CONNECTION 221
CORREZIONE DELL’IPOVITAMINOSI D [25(OH)D3] NEL PAZIENTE DIALIZZATO. EFFETTI SUL METABOLISMO CALCIO-FOSFORICO 221
Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study 220
EFFETTO DELLA TERAPIA CON INIBITORI DEL SISTEMA RENINA-ANGIOTENSINA SUI LIVELLI SIERICI DI POTASSIO NEI PAZIENTI EMODIALIZZATI. UNO STUDIO OSSERVAZIONALE 220
L’ENTITÀ’ DEL SOVRAPPESO POST-DIALITICO E’ ASSOCIATO CON LA MORTALITA’ TOTALE E CARDIOVASCOLARE NEI PAZIENTI EMODIALIZZATI. STUDIO PROSPETTICO OSSERVAZIONALE DI 36 MESI 218
Use of renin-angiotensin system blockers increases serum potassium in anuric hemodialysis patients. 217
PERITONITE DA MYCOBACTERIUM ABSCESSUS IN CAPD: CASE REPORT. 210
Varianti della malattia da anticorpi anti-GBM (mAbGBM): malattia renale da anticorpi anti-GBM in assenza di anticorpi circolanti 207
RUOLO DELLA COMPONENTE CONVETTIVA SULLE VARIAZIONI SIERICHE DI BETA 2 MICROGLOBULINA (?B2M), PROTEINA C REATTIVA (?HSCRP), E FABBISOGNO DI EPO (?EPO) IN PAZIENTI EMODIALIZZATI TRATTATI CON HDF ON-LINE POST DILUZIONALE. 192
IL RUOLO DEL GRADIENTE DIALITICO DEL SODIO SULL’AUMENTO DEI VALORI DI PRESSIONE ARTERIOSA DURANTE LA DIALISI. UNO STUDIO OSSERVAZIONALE 189
Pregnancy outcomes after kidney graft in Italy: Are the changes over time the result of different therapies or of different policies? A nationwide survey (1978-2013) 175
A prospective randomized trial on azathioprine addition to cyclosporine versus cyclosporine monotherapy at steroid withdrawal, 6 months after renal transplantation. 173
Differing dialysis treatment strategies and outcome. 166
A high calcium-phosphate product is associated with high C-reactive protein concentrations in hemodialysis patients. 166
CAVECTOMIA PER INFILTRAZIONE NEOPLASTICA DA NEOPLASIA RENALE PARENCHIMALE DESTRA 164
A controlled trial of two bicarbonate-containing dialysis fluids for CAPD--final report. 163
Nutritional treatment of advanced CKD: twenty consensus statements 162
Vascular access in older patients: an Italian survey. 161
A peritoneal dialysis solution prepared from a three-compartment bag: biological and clinical effects. 160
The MEST score provides earlier risk prediction in lgA nephropathy 160
Assessment of Vascular Structural and Functional Alterations In Apolipoprotein A-i Amyloidosis (leu75pro) 159
Magnitude of End-Dialysis Overweight is Associated with All-Cause and Cardiovascular Mortality: A 3-Year Prospective Study. 158
Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments. 155
Achievement of NKF/K-DOQI recommended target values for bone and mineral metabolism in incident hemodialysis patients: Results of the FARO-2 cohort 154
A more tubulocentric view of diabetic kidney disease 154
Endothelial dysfunction in early systemic lupus erythematosus patients and controls without previous cardiovascular events 153
Effect of post-dilutional on-line haemodiafiltration on serum calcium, phosphate and parathyroid hormone concentrations in uraemic patients. 152
A randomized controlled trial of a bicarbonate - and a bicarbonate/lactate - containing dialysis solution in CAPD 150
Association between high ultrafiltration rates and mortality in uraemic patients on regular haemodialysis. A 5-year prospective observational multicentre study. 149
A six year comparison of patient and technique survivals in CAPD and HD 148
Can tonsillectomy modify the innate and adaptive immunity pathways involved in IgA nephropathy? 144
Total Convection Affects Serum β2 Microglobulin and C-Reactive Protein but Not Erythropoietin Requirement following Post-Dilutional Hemodiafiltration 143
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events 143
Effectiveness of kidney transplantation in HIV-infected recipients under combination antiretroviral therapy: a single-cohort experience (Brescia, Northern Italy) 143
Adequacy of dialysis reduces the doses of recombinant erythropoietin independently from the use of biocompatible membranes in haemodialysis patients 141
A competing risks model with a time dependent variable: the effects of hypertension onset in the comorbidities history in type 2 diabetes 133
Access site-related infection in dialysis: the AStRID project: a multicenter prospective Italian study. 133
Inter-dialytic variations in blood volume and total body water in uraemic patients treated by dialysis. 133
Assessment of calcemic status in dialyzed uraemic patients. 131
Which vascular access for chronic hemodialysis in uremic elderly patients? 131
Monoclonal Lambda Free Liht Chains:biochemical behavoiur and pathogenetic classification 131
Correction of metabolic acidosis increases serum albumin concentrations and decreases kinetically evaluated protein intake in haemodialysis patients: a prospective study. 130
Experience with cyclosporine. 130
Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients: a longitudinal study. 129
Vascular alterations in apolipoprotein A-I amyloidosis (Leu75Pro). A case-control study 129
Effect of VDRA on survival in incident hemodialysis patients: Results of the FARO-2 observational study 129
TRANSUDATIVE PLEURAL EFFUSION DUE TO PLEUROPERITONEAL COMMUNICATION IN PERITONEAL DIALYSIS PATIENTS WITH POLYCISTIC KIDNEY DISEASE 129
Pro- and anti-inflammatory cytokine gene expression in subcutaneous and visceral fat in severe obesity 128
Adeguatezza del trattamento dialitico: aspetti pratici. 126
How to manage elderly patients with chronic renal failure: conservative management versus dialysis 126
Early (fifth day) vs. late (sixth month) steroid withdrawal in renal transplant recipients treated with Neoral((R)) plus Rapamune((R)): four-yr results of a randomized monocenter study. 126
PERITONITE IN DP: CONFRONTO TRA METODICHE 126
Porphyria and pseudo-porphyria in hemodialyzed patients. 125
Conversion of long-term kidney transplant recipients from calcineurin inhibitor therapy to everolimus: a randomized, multicenter, 24-month study. 124
Carotid Artery Structural Alterations In Patients With Apolipoprotein A-i Amyloidosis (leu75pro) 124
Dialysis initiation: what's the rush? 124
Diethylene Glycol Poisoning From Transcutaneous Absorption 123
Biosimilars and biopharmaceuticals: what the nephrologists need to know--a position paper by the ERA-EDTA Council. 123
Factors influencing the decision to start renal replacement therapy: results of a survey among European nephrologists. 123
Conservative care in Europe--nephrologists' experience with the decision not to start renal replacement therapy. 123
Interrelationships between blood pressure, blood gases and plasma acetate concentrations during conventional hemodialysis. 122
Clinical policies on the management of chronic kidney disease patients in Italy. 122
Encapsulating peritoneal sclerosis in an Italian center: thirty year experience 122
Myocardial ultrasound tissue characterization in patients with chronic renal failure 121
Management of hypertension in chronic renal failure. 121
Drugs in the elderly with chronic kidney disease: beware of potentially inappropriate medications. 121
Efficacy and safety of a very-low-protein diet when postponing dialysis in the elderly: a prospective randomized multicenter controlled study. 119
Correction of metabolic acidosis on serum albumin and protein catabolism in hemodialysis patients. 119
PD or not PD? That is the question. 119
Retroperitoneal fibrosis at the onset of ANCA associated vasculitis: The risk of a delay in the diagnosis of vasculitis 118
VDRA therapy is associated with improved survival in dialysis patients with serum intact PTH ≤ 150 pg/mL: results of the Italian FARO Survey. 118
Hepatocyte growth factor/scatter factor released during peritonitis is active on mesothelial cells. 117
Transplantation outcome in patients PD and HD 117
Role of dialysis sodium gradient on intradialytic hypertension: an observational study. 117
Tonsillectomy in a European Cohort of 1,147 Patients with IgA Nephropathy 117
Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort 117
Renal anemia: comparing current Eastern and Western European management practice (ORAMA). 116
Direct effect of the correction of acidosis on plasma parathyroid hormone concentrations, calcium and phosphate in hemodialysis patients: a prospective study. 115
Re-treatment with rituximab in ANCA-associated vasculitis only in the presence of clinical relapse: A single centre experience 115
Porphyria cutanea tarda in a haemodialysed patient. 114
Plasma catecholamine response to postural stimulation in normotensive and dialysis hypotension-prone uremic patients. 114
Renal transplantation and peritoneal dialysis 114
Steroid withdrawal five days after renal transplantation allows for the prevention of wound-healing complications associated with sirolimus therapy. 114
MALNUTRITION INFLAMMATION SCORE AND RISK OF HOSPITALISATION AND MORTALITY IN PERITONEAL DIALYSIS PATIENTS. 114
Pulmonary calciphylaxis and metastatic calcification with acute respiratory failure in multiple myeloma. 114
Impact of European medicines agency recommendations for hypersensitivity reactions on intravenous iron prescription in haemodialysis centres of the Lombardy region 113
Steroid-free immunosuppression regime reduces both long-term cardiovascular morbidity and patient mortality in renal transplant recipients 111
Ciclosporina (Cs) nei trapianti di rene: è utile il monitoraggio dei through-levels (BTL)? 111
Kidney transplantation in HIV-positive patients: a report of 14 cases 111
Evidence for an independent role of metabolic acidosis on nutritional status in haemodialysis patients. 110
Tacrolimus versus cyclosporine for early steroid withdrawal after renal transplantation. 110
A comparison between continuous ambulatory and automated peritoneal. 110
Totale 16.017
Categoria #
all - tutte 110.223
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 110.223


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.162 0 0 0 0 0 380 141 377 485 262 358 159
2021/20221.692 114 298 45 106 42 88 98 146 80 210 139 326
2022/20231.820 239 22 28 185 167 476 24 202 268 24 86 99
2023/20241.448 92 35 68 109 61 226 69 85 358 34 44 267
2024/20253.634 50 78 44 363 486 291 368 150 431 264 670 439
2025/20263.678 563 864 678 952 528 93 0 0 0 0 0 0
Totale 25.286